tiprankstipranks
Stryker Corporation (SYK)
NYSE:SYK

Stryker (SYK) Stock Price & Analysis

2,041 Followers

SYK Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$248.16 - $359.74
Previous Close$339.37
Volume1.36M
Average Volume (3M)1.31M
Market Cap
$129.28B
Enterprise Value$139.74B
Total Cash (Recent Filing)$2.41B
Total Debt (Recent Filing)$12.87B
Price to Earnings (P/E)38.8
Beta1.06
Jul 30, 2024
Dividend Yield0.93%
Share Statistics
EPS (TTM)8.75
Shares Outstanding380,949,778
10 Day Avg. Volume1,055,026
30 Day Avg. Volume1,307,002
Standard Deviation0.07
R-Squared0.47
Alpha0.00250
Financial Highlights & Ratios
Price to Book (P/B)-189.72
Price to Sales (P/S)6.37
Price to Cash Flow (P/CF)160.00
P/FCF Ratio882.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.67
Enterprise Value/Gross Profit10.70
Enterprise Value/Ebitda26.36
Forecast
Price Target Upside14.99% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering19

Bulls Say, Bears Say

Bulls Say
Financial PerformanceSYK comfortably outpaced top- and bottom-line Street estimates in 1Q while delivering organic growth of 10.0%.
Market ExpansionSYK's CEO believes there is significant opportunity for MAKO in international markets, which are just getting started with robotic technology.
Product InnovationSYK recently received FDA approval for its new LIFEPAK 35 defibrillator.
Bears Say
EarningsConsensus estimates well capture the earnings trajectory of the business.
Market CompetitionFor every OR that dV5 takes over it's a loss of $50k to SYK.
Revenue GrowthModeling Q2 Hips and Knees revenue growth of 8.0%, down from 9.5% and 10.7%, respectively.
---

Financials

Annual

Ownership Overview

24.94%22.97%16.87%35.21%
24.94% Insiders
16.87% Other Institutional Investors
35.21% Public Companies and Individual Investors

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

SYK FAQ

What was Stryker Corporation’s price range in the past 12 months?
Stryker Corporation lowest stock price was $248.16 and its highest was $359.74 in the past 12 months.
    What is Stryker Corporation’s market cap?
    Currently, no data Available
    When is Stryker Corporation’s upcoming earnings report date?
    Stryker Corporation’s upcoming earnings report date is Jul 30, 2024 which is in 12 days.
      How were Stryker Corporation’s earnings last quarter?
      Stryker Corporation released its earnings results on Apr 30, 2024. The company reported $2.5 earnings per share for the quarter, beating the consensus estimate of $2.356 by $0.144.
        Is Stryker Corporation overvalued?
        According to Wall Street analysts Stryker Corporation’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Stryker Corporation pay dividends?
          Stryker Corporation pays a Quarterly dividend of $0.8 which represents an annual dividend yield of 0.93%. See more information on Stryker Corporation dividends here
            What is Stryker Corporation’s EPS estimate?
            Stryker Corporation’s EPS estimate is $2.79.
              How many shares outstanding does Stryker Corporation have?
              Stryker Corporation has 380,949,770 shares outstanding.
                What happened to Stryker Corporation’s price movement after its last earnings report?
                Stryker Corporation reported an EPS of $2.5 in its last earnings report, beating expectations of $2.356. Following the earnings report the stock price went down -2.49%.
                  Which hedge fund is a major shareholder of Stryker Corporation?
                  Among the largest hedge funds holding Stryker Corporation’s share is Fisher Asset Management LLC. It holds Stryker Corporation’s shares valued at 1B.
                    ---

                    Company Description

                    Stryker Corporation

                    Michigan-based Stryker Corp. was founded in 1941. The company provides medical technology products and services. It operates its business through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine.
                    ---

                    SYK Earnings Call

                    Q1 2024
                    0:00 / 0:00
                    ---

                    SYK Net sales Breakdown

                    57.74%57.74%42.26%
                    57.74% MedSurg and Neurotechnology
                    42.26% Orthopaedics and Spine
                    tipranks
                    ---

                    SYK Stock 12 Month Forecast

                    Average Price Target

                    $377.82
                    ▲(14.99% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"262":"$262","298":"$298","334":"$334","370":"$370","406":"$406"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":405,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$405.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":377.82,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$377.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":350,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$350.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[262,298,334,370,406],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2023","6":"Jan<br/>2024","9":"Apr<br/>2024","12":"Jul<br/>2024","25":"Jul<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,337.25,342.46153846153845,347.6730769230769,352.88461538461536,358.09615384615387,363.3076923076923,368.5192307692308,373.7307692307692,378.9423076923077,384.15384615384613,389.36538461538464,394.5769230769231,399.78846153846155,{"y":405,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,337.25,340.3707692307692,343.4915384615385,346.6123076923077,349.7330769230769,352.8538461538462,355.9746153846154,359.0953846153846,362.2161538461538,365.3369230769231,368.4576923076923,371.5784615384615,374.6992307692308,{"y":377.82,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,337.25,338.2307692307692,339.21153846153845,340.1923076923077,341.1730769230769,342.15384615384613,343.13461538461536,344.11538461538464,345.09615384615387,346.0769230769231,347.0576923076923,348.03846153846155,349.0192307692308,{"y":350,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":299.38,"date":1689292800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":280.85,"date":1691107200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":281.58,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":263.91,"date":1696550400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":274.21,"date":1698969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":295.62,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":293.96,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":340.47,"date":1706832000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":351.58,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":350.2,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":327.68,"date":1714694400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":348.51,"date":1717718400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":337.25,"date":1720137600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Becton Dickinson
                    Edwards Lifesciences
                    Medtronic
                    Abbott Laboratories

                    Best Analysts Covering SYK

                    1 Year
                    Matt MiksicBarclays
                    1 Year Success Rate
                    21/24 ratings generated profit
                    88%
                    1 Year Average Return
                    +17.02%
                    reiterated a buy rating 3 months ago
                    Copying Matt Miksic's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +17.02% per trade.
                    Popular Stocks
                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis